日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Redox regulation of RAD51 Cys319 and homologous recombination by peroxiredoxin 1

过氧化物酶1对RAD51 Cys319的氧化还原调控及同源重组

Skoko, John J; Cao, Juxiang; Gaboriau, David; Attar, Myriam; Asan, Alparslan; Hong, Lisa; Paulsen, Candice E; Ma, Hongqiang; Liu, Yang; Wu, Hanzhi; Harkness, Trey; Furdui, Cristina M; Manevich, Yefim; Morrison, Ciaran G; Brown, Erika T; Normolle, Daniel; Spies, Maria; Spies, Michael Ashley; Carroll, Kate; Neumann, Carola A

Protein kinase Cδ is a therapeutic target in malignant melanoma with NRAS mutation

蛋白激酶Cδ是NRAS突变型恶性黑色素瘤的治疗靶点。

Takashima, Asami; English, Brandon; Chen, Zhihong; Cao, Juxiang; Cui, Rutao; Williams, Robert M; Faller, Douglas V

Stat3-targeted therapies overcome the acquired resistance to vemurafenib in melanomas.

针对 Stat3 的疗法可以克服黑色素瘤对维莫非尼的获得性耐药性

Liu Fang, Cao Juxiang, Wu Jinxiang, Sullivan Kayleigh, Shen James, Ryu Byungwoo, Xu Zhixiang, Wei Wenyi, Cui Rutao